Save
Home
GLOBAL NEWS
REUTERS
THE NEW YORK TIMES
YAHOO
INDIA BUSINESS
BUSINESS STANDARD
BUSINESS TODAY
ECONOMIC TIMES
MONEYCONTROL
THE HINDU
INDIA COMMODITIES
ECONOMIC TIMES
MONEYCONTROL
INDIA CURRENCY
ECONOMIC TIMES
MONEYCONTROL
INDIA MARKET
BUSINESS INSIDER
BUSINESS STANDARD
BUSINESS TODAY
ECONOMIC TIMES
MONEYCONTROL
NDTV
NSE
THE FINANCIAL EXPRESS
THE HINDU
INDIA MUTUAL FUNDS
BUSINESS STANDARD
ECONOMIC TIMES
INDIA MUTUAL FUNDS BLOGS
FUNDSINDIA
INDIA NEWS
BUSINESS STANDARD
ECONOMIC TIMES
FIRSTPOST
MONEYCONTROL
REUTERS
THE FINANCIAL EXPRESS
THE HINDU
YAHOO
 Save
{{newCountMsg}}
Settings

INDIA MARKET | Tue, 10 Feb 2026, 3:17PM IST Wakefit Innovations rose 7.10% to Rs 199.10 after the company reported a strong operational and financial performance for the quarter ended 31 December 2025.

Continue reading at Business Standard

9m

INDIA MARKET | Tue, 10 Feb 2026, 3:17PM IST Kiri Industries Ltd, Gokaldas Exports Ltd, Aurobindo Pharma Ltd and Kitex Garments Ltd are among the other losers in the BSE's 'A' group today, 10 February 2026.

Continue reading at Business Standard

9m

INDIA MARKET | Tue, 10 Feb 2026, 3:16PM IST Suratwwala Business Group Ltd, Barak Valley Cements Ltd, Jubilant Agri & Consumer Products Ltd and CL Educate Ltd are among the other losers in the BSE's 'B' group today, 10 February 2026.

Continue reading at Business Standard

9m

INDIA MARKET | Tue, 10 Feb 2026, 3:16PM IST Pfizer Ltd recorded volume of 8.5 lakh shares by 14:14 IST on NSE, a 86 times surge over two-week average daily volume of 9886 shares

Continue reading at Business Standard

9m

INDIA MARKET | Tue, 10 Feb 2026, 3:11PM IST Europe's benchmark share index was subdued on Tuesday as shares of BP fell after the energy giant suspended share buybacks, while gains in luxury stocks following a better-than-expected earnings update from Kering limited declines.

Continue reading at Economic Times

15m

INDIA BUSINESS | Tue, 10 Feb 2026, 3:07PM IST Indian solar module makers are facing a significant challenge as prices for Chinese solar cells surge, impacting their operations. Companies like RenewSys are contemplating costly air freight to maintain production, while others with flexible contracts are better positioned. This price volatility, rather than a supply shortage, is the primary concern for the industry.

Continue reading at Economic Times

18m

INDIA MARKET | Tue, 10 Feb 2026, 3:07PM IST India is entering a two-year period of rising interest rates, according to Ajay Srivastava. Banks and gold loan companies are set to benefit significantly. Quick Service Restaurants and Electronics Manufacturing Services companies face challenges. Investors should watch bond markets for signals. This shift presents opportunities and risks across various sectors.

Continue reading at Economic Times

19m

INDIA MARKET | Tue, 10 Feb 2026, 3:04PM IST Powered by Capital Market - Live News

Continue reading at Business Standard

21m

INDIA BUSINESS | Tue, 10 Feb 2026, 3:03PM IST Under the transaction, investment funds affiliated with Carlyle Asia Partners will invest 2,100 crore (around $230 million) in Nido. This includes a secondary purchase of a 45% stake from Edelweiss and a primary equity infusion of 1,500 crore to fund future growth. Post-transaction, Edelweiss will continue to hold a significant minority stake in the business, it said.

Continue reading at Economic Times

22m

INDIA BUSINESS | Tue, 10 Feb 2026, 3:03PM IST The receipt of this permission paves way for the marketing of Durvalumab solution for infusion 120 mg/2.4 mL and 500 mg/10 mL (Imfinzi) in India

Continue reading at The Hindu

23m

INDIA MARKET | Tue, 10 Feb 2026, 3:01PM IST Samvardhana Motherson International stock rose as much as 6.01 per cent to 131.89 on the National Stock Exchange (NSE) in Tuesday's intra-day trade.

Continue reading at Business Standard

25m

INDIA BUSINESS | Tue, 10 Feb 2026, 2:56PM IST The company reported a 14 per cent rise in revenue from operations to 31,409 crore, driven by growth in its wiring harness, electronics and diversified industrial segments

Continue reading at Business Standard

29m

INDIA MARKET | Tue, 10 Feb 2026, 2:52PM IST Axis Direct recommends UltraTech Cement, Dalmia Bharat and JK Cement after strong Q3 results, citing capacity expansion, rising demand and cost efficiencies. The brokerage sees upside potential of 814% as market share gains and margins improve over the medium term.

Continue reading at Economic Times

34m

INDIA NEWS | Tue, 10 Feb 2026, 2:51PM IST Bengaluru: Realty developer Sattva Group has entered the Mumbai Metropolitan Region (MMR) redevelopment market with six residential and commercial projects spanning over 8 million sq ft, marking the Bengaluru-based companys expansion into Indias most competitive property market.The projects, secured through competitive evaluation processes, are spread across key micro-markets including Parel (Sewri), Prabhadevi, Goregaon East, Vile Parle West, Powai and areas around the Bandra Kurla Complex (BKC). The company expects the portfolio to have a total gross development value (GDV) of about 11,000 crore.Through these redevelopment projects, Sattva plans to deliver more than 2,500 rehabilitation homes and over 2,000 new residential units. Construction is scheduled to commence in 2026 and will be executed in phases through 2032, with the first project expected to be completed by 2028.Sattvas entry comes amid a strong push for redevelopment in Mumbai, where industry estimates suggest more than 16,000 ageing buildings require reconstruction to meet modern safety, structural and sustainability norms. Regulatory refinements proposed under Development Control and Promotion Regulation (DCPR) 2034 are expected to improve project viability across Slum Rehabilitation Authority (SRA), Maharashtra Housing and Area Development Authority (MHADA) and society-led redevelopment models, thereby opening opportunities for large, financially strong developers.Industry experts note that redevelopment projects in Mumbai have gained traction as land supply remains constrained and housing demand continues to remain robust across core urban locations. The segment has increasingly attracted national developers looking to build long-term annuity and residential portfolios.Sattva said it identified the projects through a multi-parameter evaluation framework covering regulatory clarity, engineering feasibility, environmental sustainability, lifecycle asset performance and stakeholder engagement. The developer has been building local market intelligence across redevelopment clusters over the past year to align project phasing and execution strategies with regulatory processes and local development dynamics.Bijay Agarwal, Managing Director, Sattva Group, said, Mumbai is entering a defining phase of urban renewal, driven by the need to replace ageing structures with safer, well-planned, future-ready housing. Redevelopment requires clarity, discipline and long-term commitment, values central to Sattvas growth over the past three decades. Our entry into Mumbai is a strategic extension of our legacy of delivering large, technically complex projects on time and with consistency. We look forward to contributing meaningfully to the citys next decade of growth.The projects will follow a rehabilitation-led redevelopment model, under which existing residents will be provided upgraded homes along with enhanced safety systems and amenities. The company said it will deploy dedicated stakeholder engagement teams to manage transition processes and execution timelines.Sattva Group, which has a strong presence in southern markets including Bengaluru and Hyderabad, has been expanding its national footprint across residential and commercial segments. The developer has delivered about 78 million sq ft of real estate projects and currently has over 71 million sq ft under construction across multiple cities.The company is also a co-sponsor of Knowledge Realty Trust (KRT), Indias largest commercial real estate investment trust (REIT), along with global investment firm Blackstone. The REIT platform comprises 46 million sq ft of Grade A office assets across six cities.Developers expanding into Mumbai redevelopment are increasingly focusing on projects that combine technical execution capabilities with strong financial backing, as complex regulatory approvals, rehabilitation requirements and construction challenges make redevelopment among the most execution-intensive segments in Indian real estate.

Continue reading at Economic Times

35m

INDIA BUSINESS | Tue, 10 Feb 2026, 2:51PM IST Bengaluru-based Sattva Group is expanding into Mumbai's property market. The company will undertake six redevelopment projects covering over 8 million square feet. These projects aim to deliver thousands of new homes and rehabilitation units. Construction is set to begin in 2026 and continue until 2032. This move aligns with Mumbai's focus on upgrading older buildings.

Continue reading at Economic Times

35m

INDIA MARKET | Tue, 10 Feb 2026, 2:51PM IST In a recently issued circular, the Securities and Exchange Board of India (SEBI) has directed Alternative Investment Funds (AIFs) to report unit valuation data to depositories.

Continue reading at Business Standard

35m

INDIA MARKET | Tue, 10 Feb 2026, 2:50PM IST At 14:30 IST, the barometer index, the S&P BSE Sensex, jumped 180.64 points or 0.21% to 84,246.39. The Nifty 50 index fell 55.70 points or 0.21% to 25,920.20.

Continue reading at Business Standard

35m

INDIA MARKET | Tue, 10 Feb 2026, 2:46PM IST Despite a strong 2025, 2026 presents challenges. Ajay Srivastava highlights monopoly businesses like stock exchanges as key winners, while criticizing Indian IT management. He advises investors to seek technology exposure in US markets and maintain cash for volatility. Patience and selective stock picking are crucial amidst emerging US trade deal uncertainties.

Continue reading at Economic Times

40m

INDIA BUSINESS | Tue, 10 Feb 2026, 2:40PM IST AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for infusion used in cancer treatment for an additional indication. The company has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, to import for sale and distribution of Durvalumab solution for infusion of strengths 120 mg/2.4 ml and 500 mg/10 ml (brand name Imfinzi) for an additional indication, AstraZeneca Pharma said in a regulatory filing. Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy, followed by maintenance treatment with Durvalumab as monotherapy in endometrial cancer which is mismatch repair deficient (dMMR). The receipt of this permission paves way for the marketing of Durvalumab solution for infusion 1

Continue reading at Business Standard

45m

INDIA MARKET | Tue, 10 Feb 2026, 2:37PM IST Sensex Today | Stock Market LIVE Updates: In the broader markets, the Nifty MidCap and the SmallCap indices were trading 0.43 per cent 0.48 per cent, higher respectively on Tuesday.

Continue reading at Business Standard

49m

INDIA MARKET | Tue, 10 Feb 2026, 2:35PM IST Nelcast surged 9.95% to Rs 132 after the company delivered a strong performance for the quarter ended 31 December 2025, amid strong domestic demand.

Continue reading at Business Standard

50m

INDIA MARKET | Tue, 10 Feb 2026, 2:35PM IST Sales decline 49.09% to Rs 4.76 crore

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:35PM IST Reported sales nil

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:35PM IST Reported sales nil

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:35PM IST Reported sales nil

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:35PM IST Sales rise 6.25% to Rs 0.34 crore

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:34PM IST Reported sales nil

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:34PM IST Sales rise 334.38% to Rs 1.39 crore

Continue reading at Business Standard

51m

INDIA MARKET | Tue, 10 Feb 2026, 2:34PM IST Sales decline 12.33% to Rs 5.76 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:34PM IST Sales rise 9.39% to Rs 421.34 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:34PM IST Sales rise 42.63% to Rs 86.15 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:34PM IST Sales rise 8.48% to Rs 47.73 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales decline 1.94% to Rs 7.09 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales decline 0.63% to Rs 11.01 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Reported sales nil

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales rise 64.03% to Rs 2.28 crore

Continue reading at Business Standard

52m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Reported sales nil

Continue reading at Business Standard

53m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales decline 1.66% to Rs 200.50 crore

Continue reading at Business Standard

53m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales rise 110.06% to Rs 636.93 crore

Continue reading at Business Standard

53m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales rise 12.58% to Rs 61.57 crore

Continue reading at Business Standard

53m

INDIA MARKET | Tue, 10 Feb 2026, 2:33PM IST Sales rise 7.62% to Rs 22.02 crore

Continue reading at Business Standard

53m

INDIA MARKET | Tue, 10 Feb 2026, 2:32PM IST Sales reported at Rs 0.34 crore

Continue reading at Business Standard

53m

INDIA MARKET | Tue, 10 Feb 2026, 2:32PM IST Edelweiss Financial Services (Edelweiss) and global investment firm The Carlyle Group (NASDAQ: CG) today announced that investment funds affiliated with Carlyle will acquire a strategic majority stake in Nido Home Finance (Nido), a wholly-owned subsidiary of Edelweiss. As part of the transaction, investment funds affiliated with Carlyle Asia Partners (CAP) will invest Rs 2,100 crore (approximately USD 230M), which includes acquiring a 45% stake in Nido from Edelweiss through a secondary purchase and a primary equity capital infusion of Rs 1,500 crore (approximately USD 165M) in Nido.

Continue reading at Business Standard

54m

INDIA MARKET | Tue, 10 Feb 2026, 2:31PM IST Powered by Capital Market - Live News

Continue reading at Business Standard

54m
more